Digital endpoints in clinical trials of Alzheimer’s disease and other neurodegenerative diseases: challenges and opportunities

Digital endpoints in clinical trials of Alzheimer’s disease and other neurodegenerative diseases: challenges and opportunities

Alzheimer’s disease (AD) and other neurodegenerative diseases such as Parkinson’s disease (PD) and Huntington’s disease (HD) are associated with progressive cognitive, motor, affective and consequently functional decline considerably affecting Activities of Daily Living (ADL) and quality of life. St...

Full description

Bibliographic Details
Main Authors: Anna-Katharine Brem, Sajini Kuruppu, Casper de Boer, Marijn Muurling, Ana Diaz-Ponce, Dianne Gove, Jelena Curcic, Andrea Pilotto, Wan-Fai Ng, Nicholas Cummins, Kristina Malzbender, Vera J. M. Nies, Gul Erdemli, Johanna Graeber, Vaibhav A. Narayan, Lynn Rochester, Walter Maetzler, Dag Aarsland
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Neurology
Subjects:
Alzheimer’s disease
Parkinson’s disease
Huntington’s disease
neurodegenerative diseases
dementia
digital biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1210974/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2023.1210974/full

Similar Items